MOREPENLAB

HealthcareDrug Manufacturers - Specialty & GenericSmall Cap
Morepen Laboratories Limited

Morepen Laboratories Limited (MOREPENLAB) operates in the Healthcare sector, specifically as Drug Manufacturers - Specialty & Generic. The company develops, manufactures, markets, ...

हिन्दी में

Morepen Laboratories Limited (MOREPENLAB) हेल्थकेयर सेक्टर में, विशेष रूप से ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक के रूप में कार्यरत है। कंपनी एक्टिव फार्मास्युटिकल इंग्रेड...

₹136.55+2.09%1D
Previous trading day close · Data updates after market close
1W: +16.7%
1M: +23.6%
6M: +271.0%
1Y: +198.5%
62/100
AverageResearch Score
Market Cap
₹2.9K Cr
Small Cap
P/E Ratio
57.41
Premium
P/B Ratio
6.63
Premium
ROE
11.6%
Weak
ROCE
9.4%
Average
Debt / Equity
0.17
Low debt
Div. Yield
0.1%
EV/EBITDA
42.20
Expensive
52W Low: ₹33.05Current: ₹136.5552W High: ₹150.7
At 88% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
60/100
Growth
Revenue, EPS, profit growth
72/100
Valuation
PE, PB, EV/EBITDA vs sector
54/100
Risk
Debt levels, volatility, coverage
72/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
57.41(Premium)
Forward P/E
N/A
P/B Ratio
6.63(Premium)
P/S Ratio
4.13(Good)
EV/EBITDA
42.20(Expensive)
Dividend Yield
0.1%
5Y CAGR
-1.4%(Moderate)
Revenue Growth
34.1%(High)
Profitability
ROE
11.6%(Average)
ROCE
9.4%(Average)
ROA
7.7%(Average)
Net Margin
7.2%(Low)
EBITDA Margin
9.6%
Financial Health
Debt to Equity
0.17(Low debt)
Current Ratio
2.32(Healthy)
Quick Ratio
1.72(Good)
Interest Coverage
8.46x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
80(Overbought)
RSI Exp (14)
81(Overbought)
MACD
10.415(Bullish)
MACD Signal
8.926
BB Position
110%(Upper band)
BB Width
32.79%(High volatility)
ADX (14)
18.4(Sideways)
Williams %R
-9.8(Overbought)
MFI (14)
88(Overbought)
CCI (20)
247(Overbought)
Stoch %K
90(Overbought)
ATR (14)
7.14(Avg True Range)
OBV (M)
1130.3(Positive)
1W OBV Chg
12.4%(Increasing)
Rel Volume
0.91x(Normal)
Volatility
53.3%(High)
Max DD 1Y
-62.9%(High loss)
Alpha (CAPM)
184.87%(Outperforming Nifty)
Return vs Nifty
186.3%(Beating Nifty)
EMA 200
70.3
EMA 50
105.0
SMA 200
58.2
vs SMA 50
45.3%(Above SMA50)
vs SMA 200
152.6%(Above SMA200)
Volume
2.13Cr
Avg Vol 3M
217.6L
Shareholding Pattern
Promoter
35.7%
Low stake
FII
1.6%
DII / MF
1.3%
Share MOREPENLAB
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.
Morepen Laboratories Limited (MOREPENLAB) Share Price ₹136.55 Today | StockSage Pro